Eli Lilly (LLY) Stock Research, Analysis & News

Quick Analysis on Eli Lilly (LLY) Stock as of July 15, 2020

The Stock pays no dividend
Average trading volume is relatively low at 0
(See more information about Eli Lilly (LLY) Stock below)

Eli Lilly (LLY) Stock Profile Summary

Eli Lilly and Company develops, manufactures, and sells pharmaceutical products worldwide. It offers neuroscience products to treat schizophrenia, manic episodes, and bipolar maintenance; depression and diabetic peripheral neuropathic pain; attention-deficit hyperactivity disorder in children, adolescents, and adults; depression, bulimia nervosa, and obsessive-compulsive disorders; and bipolar depression and treatment-resistant depression. The companys endocrinology products are used for diabetes; type 2 diabetes; osteoporosis in postmenopausal women; osteoporosis in postmenopausal women and men at high risk for fracture; and human growth hormone deficiency and pediatric growth conditions. It also provides oncology products to treat malignant pleural mesothelioma; pancreatic, metastatic breast, non-small cell lung, ovarian, and bladder cancers; and colorectal cancers, as well as offers cardiovascular products for treating erectile dysfunction, for the reduction of thrombotic cardiovascular events in patients with acute coronary syndrome, as an adjunct to percutaneous coronary intervention, and for the treatment of adults with severe sepsis at high risk of death. In addition, the company offers animal health products, such as cattle feed additives; antibiotics used to treat respiratory diseases and other diseases in cattle, swine, and poultry; leanness and performance enhancers for swine and cattle; protein supplements to improve milk productivity in dairy cows; anticoccidial agents for use in poultry; antibiotics used to control enteric infections in calves and swine; parasiticides for use on cattle and premises; and products that prevents flea infestations on dogs, as well as other pharmaceutical products to treat staphylococcal infections and bacterial infections. Eli Lilly distributes its products principally through independent wholesale distributors, as well as directly to pharmacies. The company was founded in 1876 and is based in Indianapolis, Indiana.

Eli Lilly (LLY) Stock Key Statistics Research and Analysis as of July 15, 2020

Eli Lilly (LLY) Stock Competitor Research and Analysis

GlaxoSmithKline plc (GSK)Pfizer Inc. (PFE)
Sanofi-Aventis (SNY)Amgen Inc. (AMGN)
Biogen Idec Inc. (BIIB)Genzyme Corp. (GENZ)
Gilead Sciences Inc. (GILD)Life Technologies Corporation (LIFE)
Teva Pharmaceutical Industries Limited (TEVA)Watson Pharmaceuticals Inc. (WPI)
King Pharmaceuticals Inc. (KG)Mylan, Inc. (MYL)
Johnson & Johnson (JNJ)Novartis AG (NVS)

Mutual Funds with Eli Lilly (LLY) Stock in its top 10 holdings

FundCategoryLLY Holding Percentage
Alger Health Sciences AHealth4.6%
Amana Growth InvestorLarge Growth2.88%
Amana Income InvestorLarge Blend3.65%
Delaware Healthcare AHealth6%
Eaton Vance Worldwide Health Sci CHealth3.1%

ETFs with Eli Lilly (LLY) Stock in its top 10 holdings

Stock Research on Eli Lilly (LLY)

Latest Market News on Eli Lilly (LLY)

Click here to find the latest news on Eli Lilly (LLY)

Looking for Market Opportunties?

Today's Most Active Stocks
Today's Biggest Price % Gainers
Today's Biggest Price % Losers
Today's Unusual Rising Volume Stocks
Today's Unusual Falling Volume Stocks
Research Reports
Earning Calendar
ETF Center

See other companies in the same industry

GlaxoSmithKline plc (GSK)
Pfizer Inc. (PFE)
Sanofi-Aventis (SNY)
Amgen Inc. (AMGN)
Biogen Idec Inc. (BIIB)
Genzyme Corp. (GENZ)
Gilead Sciences Inc. (GILD)
Life Technologies Corporation (LIFE)
Teva Pharmaceutical Industries Limited (TEVA)
Watson Pharmaceuticals Inc. (WPI)
King Pharmaceuticals Inc. (KG)
Mylan, Inc. (MYL)
Johnson & Johnson (JNJ)
Novartis AG (NVS)